Everyday wellbeing
Breast changes: how do I check for cancer, understand my risk and get the right care?
How to notice breast changes, understand cancer risk and screening, prepare for diagnostic tests, and discuss treatment and follow-up. A home check cannot diagnose or rule out breast cancer.
What is breast cancer, and can I recognise it myself?
Breast cancer develops when abnormal breast cells grow without the usual controls. It often starts in the milk ducts or milk-producing lobules. Invasive cancer has grown into surrounding tissue and can spread through lymph nodes or to distant organs. Ductal carcinoma in situ (DCIS) is an abnormal growth confined to the ducts; its management differs from invasive disease. Most breast lumps are not cancer. Fluid-filled cysts, benign solid lumps called fibroadenomas, hormonal changes and inflammation can cause changes too. A lump's feel, tenderness or movement cannot reliably establish its cause at home. Breast awareness means recognising your usual appearance and feel. Screening looks for disease before symptoms. Diagnostic assessment investigates a symptom or an abnormal screening result. These serve different purposes: neither a reassuring home check nor a recent normal mammogram should stop you seeking assessment for a new change.
Which changes should I get checked, and how urgently?
Arrange a medical appointment promptly for a new lump or swelling in the breast, chest or armpit; a new change in breast shape or size; skin dimpling or thickening; a newly inward-turning nipple; a persistent nipple rash or sore; or unexplained nipple discharge, especially bloody discharge or discharge occurring without squeezing. Persistent localised breast or armpit pain also deserves assessment. Do not wait for a screening invitation, pain or a family history before asking for help. Breast cancer may be painless and may occur without a distinct lump. Skin changes may look red, darker, purple or bruised depending on skin tone. Seek same-day medical advice for a rapidly swollen, hot or painful breast, especially with fever or feeling unwell. Infection or an abscess may need treatment. Rapid breast enlargement or widespread new skin changes also need urgent assessment, even without fever: inflammatory breast cancer is uncommon but can resemble infection and may have no palpable lump. If presumed infection fails to improve as expected, return for reassessment rather than repeatedly assuming it is the same infection. Call your local emergency number for severe breathing difficulty, collapse, new confusion or other signs of serious illness. These are not typical signs of an uncomplicated breast lump. If you are the person experiencing these severe symptoms, do not drive yourself to emergency care. During cancer treatment, follow the oncology team's urgent-contact instructions for fever, chills or sudden illness. Infection can become serious quickly; do not wait until the next appointment or hide a fever with medicine before seeking advice.
How can I check my breasts or chest safely?
Choose a comfortable setting and become familiar with what is usual for you. The NHS suggests checking about monthly. If you have periods, remember that fullness and tenderness can vary during the cycle. Pregnancy, breastfeeding, menopause, hormones and surgery can also change how tissue feels. Look in a mirror with your arms relaxed, then raised. Notice changes in shape, skin or nipple position. Feel each breast or side of the chest systematically, including towards the collarbone and under the arm, using gentle and then firmer pressure without causing pain. Include the area around each nipple. A shower or lying down may make this easier. The goal is familiarity, not passing a home cancer test. A formal self-examination routine is not an adequate screening test on its own, and repeatedly pressing a worrying area does not make diagnosis more reliable. If you notice something new, record it and arrange assessment rather than checking it over and over. Illustrative example: someone notices a painless patch of thickening despite a normal screening mammogram several months ago. The useful next step is to report the new change and its location—not to wait for the next screening round.
What increases risk, and when should I ask about genetics?
Risk factors affect probability; they do not prove what caused an individual's cancer. Having none that you recognise does not exclude cancer. Increasing age and being female are major factors, although younger adults and men can develop breast cancer. Other factors include a previous breast cancer, certain abnormal biopsy findings, dense breasts, previous high-dose radiation to the chest at a young age, and inherited harmful gene changes such as BRCA1, BRCA2 or PALB2. Family history matters on both sides of the family. Men can inherit and pass on relevant gene changes too. Earlier periods, later menopause and aspects of pregnancy and breastfeeding history affect lifetime hormone exposure. Combined menopausal hormone therapy can increase risk; hormonal contraception may carry a small increase during current or recent use. Discuss benefits, alternatives and your personal risk with your prescriber rather than abruptly changing treatment. Alcohol, inactivity and excess body weight, particularly after menopause, are relevant modifiable factors. Breast cancer is not a moral failing, and healthy behaviour cannot guarantee prevention. Ask whether genetic counselling is appropriate if relatives developed breast cancer unusually young, several relatives are affected, there is male breast cancer, ovarian cancer, a known harmful variant, or a pattern including pancreatic or certain prostate cancers. Bring the relatives' diagnoses and approximate ages, if known. A positive inherited-gene result means increased risk, not a cancer diagnosis. A negative test may not remove familial risk, especially when no familial variant has been identified. A variant of uncertain significance is not the same as a confirmed harmful variant and needs specialist interpretation. Genetic risk assessment and assessment of a current lump are separate: a low risk score does not explain away a symptom.
What can reduce risk, and what cannot guarantee prevention?
Practical steps include regular physical activity, maintaining a healthy weight, and choosing not to drink alcohol or drinking less. Breastfeeding, when possible and wanted, is associated with lower risk. Discuss hormone-related treatment decisions individually. These choices can reduce risk, but none makes it zero. Screening is early detection rather than a way to prevent every cancer developing. No food, supplement, detox or home breast check should be treated as a substitute for investigation of a breast change. People at substantially increased risk may be offered an individual surveillance plan, risk-reducing medicines or, in selected very-high-risk circumstances, surgery. Medicines have potential serious harms as well as benefits; eligibility depends on factors such as menopausal status, other illnesses and local approvals. Risk-reducing mastectomy lowers risk substantially but does not eliminate it, and has physical and emotional consequences. These are specialist shared decisions, not routine recommendations for everyone.
When should I have screening, and what about dense breasts?
There is no single international screening schedule. Age ranges, intervals, funding and high-risk pathways differ. For example, the US Preventive Services Task Force recommends mammography every two years for average-risk women aged 40–74. England's NHS programme generally invites women from age 50 until their 71st birthday, every three years, with the first invitation usually between 50 and 53. These examples are not universal instructions. Ask which local programme and individual risk pathway apply to you. Screening can reduce breast cancer deaths, but it also has limitations: false alarms leading to further tests, missed cancers, and overdiagnosis of cancers that would not otherwise have caused harm. An invitation for additional images is not itself a cancer diagnosis. Attend the recommended follow-up and ask when you will receive results. Breast density describes how tissue appears on a mammogram; you cannot reliably judge it by touching your breasts. Dense tissue can make cancers harder to see and is itself a risk factor. Whether extra MRI or ultrasound is useful depends on overall risk and the local pathway. Recommendations differ, and additional screening can cause more false alarms. MRI is often part of high-risk surveillance, rather than an automatic replacement for mammography. If you have symptoms, ask for diagnostic assessment rather than merely booking routine screening. If your records, gender marker, surgery or hormone use affect invitations, ask the service directly about eligibility and suitable tests.
What happens when a clinician assesses a breast change?
The clinician asks when you first noticed the change, whether it is growing, whether pain varies with your cycle, and whether there is discharge, fever, pregnancy or breastfeeding. They also consider medicines, previous breast problems, imaging and family history. Examination may include both breasts, nipples, armpits and nearby lymph nodes. Ask for a chaperone, an interpreter or a support person if helpful. Breast assessment commonly combines clinical examination, appropriate imaging and, when indicated, a tissue sample. Not everyone needs every test. A diagnostic mammogram provides X-ray views directed at the concern. Ultrasound can help characterise a lump, including whether it is fluid-filled or solid, and guide sampling. MRI is useful in selected situations. Test choice depends on age, the examination and pregnancy or breastfeeding status, not simply a preference for the most elaborate scan. If a suspicious area needs sampling, a needle biopsy removes material for laboratory examination; a core biopsy takes small tissue samples. Some situations need another biopsy approach. Imaging can identify suspicious changes, but tissue examination establishes a cancer diagnosis. Ask about preparation, pain relief, blood-thinning medicines and aftercare; do not stop prescribed medicines without instructions. Blood tests alone cannot reliably rule out breast cancer. A normal image is also not the end of assessment when the examination and ongoing symptom remain concerning. Ask whether the findings explain the exact change you reported and what the follow-up plan is. Appointment preparation tool: note which side and location, when it began, changes over time, related skin or nipple symptoms, medicines, previous breast tests and family diagnoses. Keep the information private. Before leaving, write down who will contact you, when results are expected and whom to call if nothing arrives. Do not assume silence means a normal result.
What do biopsy results, stage and tumour markers mean?
A biopsy may show a benign condition, a higher-risk abnormality, DCIS or invasive cancer. Ask for an explanation of the actual report rather than relying on a label alone. If cancer is found, grade describes how abnormal the cells look and helps estimate behaviour. Stage describes disease extent and incorporates other biological information. Stage is not determined by a lump's size alone. Stage IV means spread to distant parts of the body; spread to nearby armpit lymph nodes is not automatically stage IV. Tests for oestrogen receptors (ER), progesterone receptors (PR) and HER2 help select treatment. Hormone-receptor-positive cancers may respond to endocrine treatment. HER2-positive cancers may benefit from HER2-directed medicines. Triple-negative means ER, PR and HER2 tests are negative; it does not mean there are no treatment options. Selected cancers have additional tumour gene-activity tests to guide decisions such as whether chemotherapy is likely to help. These tests differ from inherited-gene testing. Additional scans are chosen to answer specific staging questions; not everyone needs CT, PET or every available scan.
How is breast cancer treated?
A specialist team considers disease extent, tumour biology, general health, pregnancy, personal priorities and available treatments. Two people with similar-sized lumps may appropriately receive different treatment. Ask about the treatment's purpose and expected absolute benefit, not just its name. Surgery may remove the cancer with a surrounding margin while retaining most of the breast, or remove the breast by mastectomy. Selected lymph nodes may be sampled to assess spread. A sentinel-node procedure examines the first draining nodes and may avoid more extensive surgery in suitable cases. The appropriate operation varies; mastectomy does not automatically improve survival for every early cancer compared with suitable breast-conserving treatment. Discuss reconstruction, remaining flat or an external prosthesis if relevant. Radiotherapy treats a defined area. It is commonly used after breast-conserving surgery and sometimes after mastectomy; it can also help control symptoms in advanced disease. Systemic medicines reach beyond the operation site. Chemotherapy is useful for some cancers, but not everyone needs it. Endocrine treatment blocks hormone-driven growth in suitable cancers and may continue for years. Targeted treatments act on particular cancer features. Immunotherapy is used in selected circumstances, including some triple-negative cancers. Drug selection, sequencing, monitoring and duration require an individual plan. Treatment may be given before surgery to reduce disease or guide later decisions, or afterwards to lower recurrence risk. DCIS, invasive early cancer, inflammatory cancer and metastatic cancer do not all follow the same pathway. Metastatic breast cancer is generally treated to control disease, relieve symptoms and help people live longer; it is usually not curable. Palliative care can support comfort and quality of life alongside active cancer treatment. Clinical trials may be appropriate; participation is a choice, not a guarantee of benefit.
What if I am pregnant, breastfeeding, male or have had chest surgery?
Pregnancy and breastfeeding can make breasts fuller or lumpier, but a persistent new lump or unusual change still needs assessment. Ultrasound is often the first investigation in pregnancy; further imaging and biopsy can be arranged when needed. Do not postpone assessment until after delivery or weaning. Cancer treatment during pregnancy requires coordinated specialist care because the type and timing of treatment matter. If treatment is needed, ask specifically about breastfeeding safety; some cancer medicines are unsafe for a nursing baby. Men should also report new breast or nipple changes. Transgender and non-binary people may retain breast tissue after chest surgery; risk and suitable investigations depend on anatomy, surgery, hormone exposure and other factors. Do not assume that lack of a routine screening invitation means a symptom can be ignored.
What follow-up and support should I expect?
Ask for a written plan covering treatment, likely side effects, follow-up tests, ongoing medicines and urgent-contact numbers. Rehabilitation may address shoulder movement, pain and lymphoedema, which is swelling related to lymph drainage. Seek support for fatigue, anxiety, body image, sexual symptoms, menopause and practical or financial difficulties. Discuss fertility preservation and pregnancy plans before treatment starts if relevant. Tell the team about supplements and complementary treatments because they may interact with medicines. Do not replace proven treatment with an unproven alternative. After treatment, report new or worsening symptoms rather than waiting for the next planned visit. Follow-up is tailored to your treatment and remaining breast tissue; it does not necessarily mean repeated whole-body scans. If a breast change was initially considered benign but persists, grows or changes, return for reassessment and ask whether further imaging, sampling or specialist review is needed.
Questions worth taking to the appointment
- What is the likely explanation, and which findings still need clarification? - Does my examination match the imaging result? Do I need a biopsy? - When will I receive results, who will contact me, and whom should I call if they are delayed? - Does my family history justify specialist risk assessment or genetic counselling? - Which screening schedule applies to me, including any dense-breast or high-risk pathway? - If cancer is confirmed, what are its type, stage, grade and ER/PR/HER2 results? - What benefit do you expect from each treatment, what are the main harms, and what alternatives fit my situation? - How might treatment affect fertility, pregnancy, breastfeeding, work and daily life? - Which symptoms need a same-day call or emergency care, and what is my follow-up plan? This guide uses international wording. Referral routes, screening eligibility, test availability, treatment approvals and emergency numbers differ between countries. If services are difficult to access, ask a local primary-care service or cancer service how to obtain assessment; do not wait for an organised screening programme to investigate a symptom.
Sources and further reading
NHS — Symptoms of breast cancer
NHS — How to check your breasts or chest
NHS — Causes and risk reduction
NCI — Benign and precancerous breast conditions
NCI — Breast cancer causes and risk factors
NCI — BRCA gene changes and genetic testing
CDC — Reducing breast cancer risk
NCI — Breast cancer prevention
USPSTF — Breast cancer screening recommendation
NHS — Who breast screening is for
NCI — Choosing lumpectomy or mastectomy
NCI — Inflammatory breast cancer
NCI — Breast cancer during pregnancy
NCI — Living with breast cancer and survivorship
NCI — Infection during cancer treatment
Sources accessed 2026-10-21. Local care pathways vary. These guides use international wording; emergency numbers and services depend on your location.
This guide is general education, not a diagnosis or treatment plan. Content is AI-assisted. Clinical review applies to the article version and date shown above. Read our editorial policy. Report an error or suggest a correction.